J Biol Chem, Vol. 274, Issue 30, 20895-20900, July 23, 1999
Targeting Expression with Light Using Caged DNA*
W. Todd
Monroe
,
Mark M.
McQuain
,
Min S.
Chang§,
J. Steven
Alexander
¶, and
Frederick R.
Haselton
§
From the Departments of
Biomedical Engineering and
§ Ophthalmology, Vanderbilt University,
Nashville, Tennessee 37235
 |
ABSTRACT |
In this report, we describe the inactivation and
site-specific light induction of plasmid expression using a
photosensitive caging compound. Plasmids coding for luciferase were
caged with 1-(4,5-dimethoxy-2-nitrophenyl)diazoethane (DMNPE) and
transfected into ~1-cm diameter sites of the skin of rats with
particle bombardment. Skin sites transfected with caged plasmids did
not express luciferase. However, subsequent exposure of transfected
skin sites to 355-nm laser light induced luciferase expression in
proportion to the amount of light. Liposome transfection of HeLa cells
with DMNPE-caged green fluorescent protein (GFP) plasmids showed
similar results. Caging DNA with DMNPE blocks expression at the level
of transcription, since in vitro production of mRNA
from linearized GFP plasmid was also blocked by caging and subsequently
restored by exposure to light. Under the reaction conditions of these
experiments, our absorbance data indicate that each DMNPE-caged GFP
plasmid contains ~270 caging groups. In addition to inhibition and
subsequent restoration of plasmid bioactivity, the presence and
photocleavage of this relatively small number of cage groups also
alters electrophoretic mobility of plasmids and optical absorption
characteristics. This light-induced expression strategy provides a new
means to target the expression of genetic material with spatial and
temporal specificity.
 |
INTRODUCTION |
The unrealized goal of in vivo gene therapy is the
controlled expression of exogenous genes exclusively within a target
cell population. Successful in vivo gene therapy must
overcome two significant challenges: 1) delivery of transgenes to the
specific target cell population and 2) subsequent expression only
within these cells. Viral and nonviral technologies for delivery of
transgenes to specific target cells are currently under development,
but none of these techniques is suitable in its current form for
targeted delivery of transgenes in vivo.
Nonspecific delivery of "silent" genes followed by site-specific
induction is one potential targeting strategy. Several postdelivery expression strategies have been described (1). These may be broadly
classified into induction by tissue-specific promoters and induction by
changes in the cellular environment. Tissue-specific promoters (2, 3)
remain a promising technique but must be developed for each target cell
population. Most current induction strategies add factors to the
cellular milieu to control expression. These factors include metal ion
concentration (4, 5), tetracycline (6, 7), hormones (8-10), and
recently RNA-binding aptamers (11). However, targeted expression with
environmental induction agents is difficult, since it requires limiting
the in vivo distribution of the induction agents solely to
the target cell population. To achieve site-specific expression, a
strategy permitting spatially targeted induction is needed.
In this report, we describe a targeting strategy based on "cage"
chemistry. Caged compounds have a covalently attached group that is
rapidly cleaved upon exposure to near-UV light. Attachment of the
caging compound renders the bioactive molecule inert, until photolysis
releases it in its bioactive form (12, 13). Caged compounds have been
used in a number of temporal biological studies to examine cell
motility, the chemistry of muscle contractility, active transport
proteins, biological membranes, and other intracellular responses (14,
15). Cage compounds have also been used in the caging of nucleotide
analogs (16), in the synthesis of biochip oligonucleotides (17), and
most recently to temporally control ribozyme reactions by including
caged adenosine within synthesized RNA oligonucleotides (18).
Application of caging chemistry to plasmid DNA offers the possibility
of light-activated expression after delivery to cells, and furthermore,
since light exposure can be spatially controlled, this photoactivation
approach has the potential to produce targeted expression.
 |
EXPERIMENTAL PROCEDURES |
Plasmid Caging with
DMNPE1--
5 mg of
4,5-dimethoxy-2-nitroacetophenone hydrazone and 50 mg of manganese(IV)
oxide were gently agitated in 1 ml of Me2SO at 25 °C for
20 min (Molecular Probes, Inc., Eugene, OR). Manganese oxide was
removed from the activated caging compound by filtering the solution
through 100 mg of CeliteTM supported by glass wool in a 1 cm3 tuberculin syringe. 150 µl of the filtrate was
agitated with 150 µg of plasmid DNA in 300 µl of TE buffer (10 mM Tris-Cl, 1 mM EDTA, pH 7.4) for 24 h at
4 °C. In order to remove all excess caging compound from the
reaction, the caged plasmid DNA was extracted twice with an equal
volume of chloroform, followed by ethanol precipitation. Caged plasmids
were stored in TE buffer at 4 °C, protected from light.
Spectral Scanning Protocol--
pGreenLantern-1 plasmid (pGFP,
Life Technologies, Inc.), DMNPE-caged pGFP, ATP, and DMNPE-caged ATP
(Molecular Probes) were dissolved in water in separate cuvettes (pGFP,
135 µg/ml; ATP, 55 µg/ml) and scanned for absorbance from 200 to
450 nm (Perkin-Elmer Lambda 900 Spectrometer). After an initial scan,
the cuvette contents containing caged pGFP and caged ATP were exposed
to 365-nm light at a distance of 10 cm for 20 min. This lamp has a peak
output at 365 nm and a fluence rate of 4.68 milliwatts/cm2
at 10 cm (Blak Ray, San Gabriel, CA; model B 100 AP). Spectrographic characterization of this lamp confirmed that the emission spectrum is
365 ± 8 nm (Triax-180 spectrograph; Instruments S.A., Edison, NJ). Approximately 5 min after the light exposure ended, the cuvette contents were rescanned, and the postlight absorbances were compared with the prelight spectra.
Calculation of Caging Efficiency from Absorbance
Measurements--
The extinction coefficient
(
= 355) of the bound caging DMNPE group was
calculated from the local absorbance peak at 355 nm before exposures to
365-nm light of commercially available DMNPE-caged ATP (Molecular
Probes). The extinction coefficient for DMNPE-ATP
(
= 355) was obtained from the expression,
|
(Eq. 1)
|
where A
= 355 represents absorbance
at 355 nm, c represents molar concentration of solution, and
b represents path length of the cuvette (1 cm). The
concentration value (75 µM) used in this calculation was
adjusted to account for the 89% of ATP that was reported to be caged
(19). The extinction coefficient was then used to determine the molar
concentration of DMNPE in the caged plasmid samples by measuring the
absorbance at 355 nm. From these data, an average number of DMNPE
caging groups per plasmid was then calculated.
DNA Gel Electrophoresis--
150 ng of pGreenLantern-1 plasmid
per well was run in 1% agarose in Tris acetate buffer (4 mM Tris acetate, 0.1 mM EDTA, pH 8.5) at 5 V/cm
for 1 h 45 min. Gels were stained after electrophoresis with 1×
SYBR-Gold nucleic acid gel stain (Molecular Probes) in 1× Tris acetate
buffer for 15 min. The line profile analysis tool in Image Pro Plus
Software (Media Cybernetics, Silver Spring, MD) was used to quantify
band intensities.
In Vitro Transcription--
BamHI-linearized
pGreenLantern-1 plasmid was used as the template for the
MEGAscriptTM In Vitro Transcription Kit (Ambion
Inc., Austin, TX, catalog no. 1330). 1 µg of DMNPE-caged and control
plasmid templates were incubated for 4 h at 37 °C in the enzyme
mixture supplied with the kit. Immediately prior to incubation, one
caged sample was exposed to 365-nm light as described above. Gels were
stained after electrophoresis with 1× SYBR-Gold nucleic acid gel stain (Molecular Probes) in 1× MOPS buffer (10 mM MOPS, 0.1 mM EDTA, pH 8.5) for 25 min. 5 µl of RNA product from the
kit was run in 1.5% agarose-formaldehyde in 1× MOPS buffer at 4 V/cm
for 1 h. For caged samples, 10 µl of kit product was loaded to
improve visualization of the caged versus caged
light-exposed bands. Gel band intensities were quantified using the
summation statistics tool in Image Pro Plus Software (Media
Cybernetics, Silver Spring, MD). Intensity values for each pixel were
summed for each lane of the gel. Background values were measured over
three separate empty lanes of the gel (not shown), averaged, and
subtracted from all other measured values.
Caged Green Fluorescent Protein (GFP) Expression in HeLa
Cells--
HeLa cells were liposome-transfected with plasmids coding
for GFP. 1 µg of pGreenLantern-1 plasmid was complexed with 6 µg of
liposome in 100 µl of Opti-MEM medium (Life Technologies) and used
for transfection. Cationic liposomes
(Dioleoyl-3-Trimethylammonium-Propane/Dioleoyl Phosphatidylethanolamine, 1:1) were prepared by vacuum evaporation followed by extrusion to yield unilamellar liposomes of 0.1 µm as
described previously (20). HeLa cells were seeded onto 35-mm Petri
dishes (Fisher) at 20,000 cells/cm2 16-18 h before
transfection. 1 ml of the DNA-liposome complex in Opti-MEM was added to
the cell culture dishes for 3.5 h, after which the solution was
replaced with 1 ml of Opti-MEM.
Both pre- and post-transfection effects of light were investigated. To
study light-induced plasmid damage, matched cultures were transfected
with plasmids that had been exposed to 5 J/cm2 of light
with the lamp described in the spectral scanning protocol, or no light
before transfection. In a second group of cultures, after liposomal
transfection with unexposed plasmids, culture dishes were individually
exposed to 0.5, 2.6, or 5.6 J/cm2 of light from the same
light source. A third group of samples was transfected with unexposed
DMNPE-caged pGFP and exposed to light in the same manner as the second group.
Following light exposure, Opti-MEM medium in all culture dishes was
replaced with 2 ml of Dulbecco's modified Eagle's medium plus 10%
calf serum. 48 h after transfection, cells were washed with cold
calcium- and magnesium-free/phosphate-buffered saline twice,
trypsinized (0.15%) and paraformaldehyde-fixed (1%) for 5 min at room
temperature. The fixed cells were then washed with calcium- and
magnesium-free/phosphate-buffered saline containing 1% formaldehyde
three times, resuspended in calcium- and
magnesium-free/phosphate-buffered saline containing 1% formaldehyde,
and stored at 4 °C for flow cytometric analysis. Transfection
samples were analyzed by a FACSCalibur (Becton-Dickinson) flow
cytometer equipped with an argon laser exciting at a wavelength of 488 nm. For each sample, 20,000 gated events were collected by list-mode
data consisting of side scatter, forward scatter, and fluorescence
emission centered at 530 nm (FL1), 580 nm (FL2), and 610 nm (FL3).
Determination of positive events for GFP expression was made using a
standard gating technique (20). Cytometric results from a
nontransfected control sample were displayed on a dot plot of FL3
versus FL1 fluorescence intensity. A gate was drawn along a
line of maximum detected FL1 intensity for the control events. This
gate was kept constant through analysis of all subsequent measurements.
The percentage of GFP-positive cells was calculated as the ratio of the
number of events within this gate divided by the total number of events collected.
Particle-mediated Gene Delivery--
The plasmid used for
in vivo rat studies was the luciferase expression plasmid
pCEP4 coding for luciferase and containing the SV40 Poly(A) signal
(Promega, Madison, WI). Particle-mediated gene delivery was achieved as
reported in Ref. 21. Briefly, plasmid DNA was precipitated on gold
particles (2 µm in diameter) in the presence of 50 mM
spermidine and 0.5 M CaCl2 at a final concentration of 2 µg of DNA/µg of gold. The DNA-gold complexes were washed extensively with absolute ethanol and resuspended in
absolute ethanol. The suspension was then used to coat the interior of
-inch outside diameter Tefzel tubing (McMaster-Carr Supply
Co., Elmhurst, IL) in a specially designed loading and drying apparatus
(Agracetus, Inc., Elmhurst, IL). After the particles adhered to the
tubing, it was cut into 1/2-inch lengths such that 0.5 µg of
DNA-coated gold particles would be delivered with each dose. Prepared
tubing segments were stored at
20 °C in a sealed, desiccated
container. At the time of the experiment, the DNA-gold-coated tubes
were brought to room temperature, loaded into the cylinder of the
delivery device, and accelerated into the tissue by a rapid release of
a pulse of helium with an electrically controlled valve at 400 p.s.i. Particles were deposited in a circular pattern with a diameter
of ~0.8 cm. Male Harlan Sprague Dawley rats (250-300 g; Harlan
Sprague Dawley, Inc., Indianapolis, IN) were housed in the Vanderbilt
Veterans Affairs animal care facility maintained according to the
American Association for Accreditation for Laboratory Animal Care
Standards. The animals were allowed food and water ad
libitum. All transfection and surgical procedures are carried out
under general anesthesia with ketamine and xylazine. All animal
procedures were approved under the guidelines of the local animal care
and use committees. Cutaneous transfections were carried out with the
animal under general anesthesia. Two rows of three sites per row
distributed transversely across the dorsal surface were transfected
with a single dose of the expression construct or caged DNA. The site
was prepared by clipping the pelt and by treatment with the depilatory
agent, Neet (Reckitt and Colman Inc., Wayne, NJ) according to the
manufacturer's recommendations. The plasmid-gold complexes were then
transfected into the skin at the selected pressure by placing the
muzzle of the gene gun in contact with the site. Within 1 h of
particle-mediated gene transfer, selected transfection sites on each
rat were exposed to targeted pulses of light with a Nd:YAG laser tuned
to 355 nm (Vanderbilt University Free Electron Laser Facility). The
total dosage for each site was either 1 or 10.8 J/cm2.
Light was delivered in 10-mJ pulses at 10 Hz. The light pattern was
circular and matched the dimensions of the transfection region. 24 h after transfection, animals were killed by carbon dioxide poisoning,
pelts were removed, and tissue from transfection sites was isolated and
halved. One half was sectioned, imaged, and analyzed in Image Pro Plus
to determine average bead depth. The other half of each transfection
site was homogenized in a lysis buffer containing 100 mM
potassium phosphate, pH 7.8, and 1.0 mM dithiothreitol, 0.1% Triton X-100, and 10 mg/ml phenylmethylsulfonyl fluoride at
4 °C. Luciferase activity was measured in 20-µl aliquots of tissue
lysate, with a 100-µl luciferase assay buffer consisting of 5 mM ATP, 15 mM MgCl2, and 1 mM D-luciferin as provided by Promega using a
liquid scintillation counter (Packard Instrument Co.) set for single
photon counting. The luciferase activity was expressed as
counts/min.
 |
RESULTS |
Spectral Scans--
Fig. 1 shows the
similarity of the absorbance spectra of DMNPE-caged pGFP plasmid
prepared for these studies (top) and DMNPE-caged ATP
obtained from Molecular Probes (bottom). The
upper solid curves are absorbance
spectra before caged materials were exposed to light, and the
dashed curves are spectra obtained 5 min after exposure to 20 min of 365-nm light. Light produced similar shifts in
absorbance at 355 nm for both DMNPE-caged pGFP and commercially available DMNPE-caged ATP. After exposure to 365-nm light, increases in
absorbance at 390 nm are observed for both compounds. This is
presumably produced by photolysis of the caging group attached to ATP
and pGFP. Native DNA plasmids and ATP do not absorb in the region from
300 to 450 nm (lower solid
curves).

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 1.
Pre- and postphotolysis spectra DMNPE-caged
ATP and DMNPE-caged pGFP. pGFP and DMNPE-caged pGFP, ATP, and
DMNPE-caged ATP (Molecular Probes, Eugene) were dissolved in water in
separate cuvettes (pGFP, 135 µg/ml; ATP, 55 µg/ml) and scanned for
absorbance from 200 to 450 nm. After an initial scan (upper
solid curves), the cuvette contents containing
caged samples were exposed to 20 min of 365-nm light and were rescanned
approximately 5 min after light exposure ended (upper
dashed curves). The lamp used has a peak output
at 365 nm and a fluence rate of 4.68 milliwatts/cm2 at 10 cm. Native DNA plasmids and ATP do not absorb in the region from 300 to
450 nm (lower solid curves).
|
|
DNA Gel Electrophoresis--
Electrophoresis of caged plasmids
shows characteristic changes in mobility corresponding to the addition
and removal of the caging groups (Fig.
2). Typical plasmid conformation bands
are observed; the bands with greatest mobility correspond to multiple conformations observed with supercoiled bands (S), the least
mobile bands correspond to the nicked conformations (N), and
the bands that appear between these two groups are presumed to be
relaxed (R) (22). The markers in lane
A are from an EcoRI digest of
DNA.
Lane B is caged plasmid. Lane
C contains caged light-exposed plasmid exposed to 20 min of
365-nm light. Lane D contains plasmid that was
exposed to the caging reaction conditions but without the caging
compound. Qualitatively, the greatest change produced by light is seen
in the redistribution of the relaxed bands. To characterize the shifts
in gel banding pattern between caged (B) and caged
light-exposed plasmids (C), the areas under each of the
relaxed band peaks (R) were calculated and compared for both caged and caged light-exposed plasmids. In the caged sample, the bands
are approximately 1:1 in intensity. The distribution of amounts in
these bands changes with light exposure, since this ratio for the caged
light-exposed plasmid is 3:7, with the greater intensity in the most
mobile band.

View larger version (86K):
[in this window]
[in a new window]
|
Fig. 2.
DNA gel of caged and caged light-exposed
samples of GFP plasmids. 150 ng of plasmid/well was run in 1%
agarose in Tris acetate buffer at 5 V/cm for 1 h 45 min. The
markers in lane A are from an EcoRI
digest of DNA. Lane B is caged plasmid.
Lane C contains caged light-exposed plasmid
exposed to 20 min of 365-nm light. Lane D
contains plasmid that was exposed to the caging reaction conditions but
without the caging compound. Typical plasmid conformation bands are
observed; the bands with greatest mobility correspond to multiple
conformations observed with supercoiled bands (S), the least
mobile bands correspond to the nicked conformations (N), and
the bands that appear between these two groups are presumed to be
relaxed (R) (22).
|
|
In Vitro Transcription Results--
Fig.
3 shows a denaturing agarose gel of
mRNA products from the in vitro transcription of
DMNPE-caged plasmids. Caged pGFP plasmids are not transcribed in
vitro (D). Caged light-exposed plasmids produce an
mRNA band (E) with an amount similar to that produced by
native plasmids (B) and caging reaction controls
(C). In Fig. 3, the intensities for the native template and
the template subjected to the extraction and isolation procedures of
the caging reaction were within 10% of each other (103,264 and 114,830 counts, respectively). These values were averaged and used as a
standard for comparison. The caged template and caged light-exposed
template samples showed intensities of 35,522 and 59,311 counts. These values were halved to account for the increased (2×) loading of the
caged and light-exposed lanes, resulting in mRNA production estimates of 3.6% for caged and 19% for caged light-exposed as percentages of the average mRNA production from the native
template.

View larger version (128K):
[in this window]
[in a new window]
|
Fig. 3.
Agarose-formaldehyde gel (1.5%) of mRNA
from in vitro transcription reaction of caged and
caged light-exposed plasmids. BamHI-linearized Green
Lantern plasmid was used as the template for the MEGAscript In
Vitro Transcription Kit (Ambion Inc., Austin, TX; catalog no.
1330). B, mRNA product for native pGFP plasmids;
C, caging reaction controls; D, caged pGFP;
E, caged light-exposed pGFP. Lanes D
and E were loaded with twice as much of the transcription
kit product to improve visualization of the caged versus
caged light-exposed bands.
|
|
GFP Expression in HeLa Cells--
The expression level of native
pGFP was 43 ± 3.9% (n = 11, mean ± S.E.,
gray bars, Fig. 4).
Within each experiment, the percentages of GFP-positive cells were
normalized with this positive control group. Without exposure to light
(i.e. with 0 J/cm2 of 365-nm light) the fraction
of HeLa cells that express caged pGFP (solid bar)
is about one-fourth of the level of expression of native material
(25.8%, n = 7). After exposure to 0.25 or 0.5 J/cm2 of light, expression of the caged material increases
to 50% of control. The asterisks above these
bars indicate significant difference from expression of
caged plasmids that received no light exposure (p < 0.05, Bonferroni's t test). Beyond 0.5 J/cm2,
increased light dosages caused a decrease in expression levels of caged
pGFP. Cultures transfected with caged pGFP and treated with 2.8 and 5.6 J/cm2 of light showed expression levels of 20 and 10% of
control, respectively. These results were obtained from transfection
experiments using caged plasmids from a single caging reaction.
Products from other caging reactions produced varying amounts of
expression between the caged and light-exposed states. These
differences are most evident in the cage's ability to block expression
and varied from almost 0% expression to ~25% of control. However,
caged plasmids from all reactions showed similar trends with at least a
doubling of GFP expression after light exposure.

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 4.
Effect of light on native and caged GFP
expression in HeLa cultures. HeLa cells were liposome-transfected
with caged and native GFP plasmids. The expression level of native pGFP
was 43 ± 4.3% of cells (n = 11, mean ± S.E.). Percentages of expression were normalized to this group. Without
exposure to light (i.e. with 0 J/cm2 of 365-nm
light), the fraction of HeLa cells that express caged pGFP
(solid bar) is 25.8% of native plasmid
expression levels (n = 7, gray
bars). After exposure to 0.25 or 0.5 J/cm2 of
light, expression of the caged material increases to 50% of control.
The asterisks indicate significant difference from
expression of caged plasmids that received no light exposure
(p < 0.05, Bonferroni's t test). Cultures
transfected with caged pGFP and treated with 2.8 and 5.6 J/cm2 of light showed decreasing expression levels of 20 and 10%, respectively. Native GFP expression levels also decreased
with increasing post-transfection light exposure, from a normalized
100% with no light exposure to 81, 24, and 10% with a light exposure
of 0.5, 2.6, or 5.6 J/cm2, respectively. Cultures exposed
to 2.8 or 5.6 J/cm2 of light after transfection showed
significantly lower levels of expression than those that received no
light (denoted by crosses, p < 0.05, Bonferroni's t test). Plasmids exposed to the highest dose
of light (5.6 J/cm2) before transfection (bar
labeled Pre-Flash) express at levels equal to control
plasmids that received no light.
|
|
Decreased expression of caged plasmids appeared to be reduced by higher
levels of light exposure. This decrease in expression with increasing
365-nm light dosage was also observed for native pGFP plasmids. GFP
expression levels decreased as post-transfection light exposure
increased, from a normalized 100% with no light exposure, to 81, 24, and 10% with light exposures of 0.5, 2.6, or 5.6 J/cm2,
respectively. As shown in Fig. 4, cultures exposed to 2.8 or 5.6 J/cm2 of light after transfection showed significantly
lower levels of expression (denoted by crosses,
p < 0.05, Bonferroni's t test) than those
that received no light. This decrease is evidently not an effect of
light on plasmid structure, since pGFP plasmids exposed to the highest
dose of light (5.6 J/cm2) before transfection
(bar labeled Pre-Flash) express at
levels equal to control plasmids that received no light.
In Vivo Results--
Luciferase expression of skin sites
transfected with caged plasmid is equal to background levels measured
in nontransfected skin. Exposure of skin sites transfected with caged
plasmids to increasing amounts of 355-nm laser light increased
expression to 6 ± 3, 12 ± 4, and 17 ± 6% of control,
respectively. The right bar indicates the highest
expression (40 ± 12% of control) from skin sites transfected
with caged plasmids exposed to light before delivery (Fig.
5). The asterisks indicate
difference from no light exposure by two-way repeated measures analysis
of variance (n = 4; mean ± S.E.).

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 5.
Effect of light on luciferase expression in
rat skin. Particle-mediated transfection of caged and native
pCEP-luciferase was performed on ~1-cm diameter sites in rat skin.
Luciferase expression of skin sites transfected with caged plasmid is
equal to levels in nontransfected skin. Exposure of skin sites
transfected with caged plasmids to increasing amounts of 355-nm laser
light increases expression to 6 ± 3, 12 ± 4, and 17 ± 6% of control, respectively. The right bar
indicates highest expression (40 ± 12% of control) from skin
sites transfected with caged plasmids exposed to light before delivery.
The asterisks indicate difference from no light exposure by
two-way repeated measures analysis of variance (n = 4;
mean ± S.E.).
|
|
 |
DISCUSSION |
We used a simple in vivo test to demonstrate the
feasibility of light-induced expression and its potential for targeting
expression. Plasmids coding for luciferase were caged with
1-(4,5-dimethoxy-2-nitrophenyl)diazoethane and transfected into ~1-cm
diameter sites of rat skin with gold particle bombardment (21). The
presence of the DMNPE cage groups on plasmids blocks expression; sites
transfected with caged plasmids have expression levels equal to
nontransfected skin sites (Fig. 5). However, luciferase expression is
induced at sites transfected with caged plasmid and subsequently
exposed to 355-nm laser light. A low dose of 355-nm light (1 J/cm2) increases luciferase expression to 6 ± 3% of
positive control. Increasing the light dosage by an additional factor
of 10 and 20 produces additional increases in luciferase expression to
12 ± 4 and 17 ± 6% of positive control. Caged plasmids
subjected to 1.6 J/cm2 of light before particle-mediated
delivery result in skin sites with the highest expression and are
40 ± 12% of positive control.
Results from cytometric analysis of HeLa cells liposome-transfected
with DMNPE-caged GFP plasmid also show that caging can reversibly block
expression. Cells transfected with caged pGFP do not express GFP at the
levels of cultures transfected with native pGFP. However, with exposure
to 0.5 J/cm2 light, GFP expression is induced and increases
from 25 to 50% of positive controls (Fig. 4). When doses of light
greater than 0.5 J/cm2 were applied to the transfected
cultures, expression levels decreased. This decrease was further
characterized in tests of 365-nm light exposure on native pGFP
expression. As shown by the gray bars in Fig. 4,
increasing the light dose decreases the percentage of GFP-expressing
cells transfected with native pGFP. Light levels above a threshold
level 0.5 J/cm2 produced significantly lower levels of
expression of native pGFP plasmid. In cultures transfected with native
pGFP that had been given the highest exposure of light prior to
transfection, expression levels were identical to nonexposed controls.
This latter observation suggests that the decrease in expression is not
due to plasmid damage caused by light exposure.
Subsequent in vitro investigation suggests that the
mechanism of expression blockade occurs at the transcriptional level. In an in vitro transcription assay, caging DNA blocks
mRNA production, but after light-induced photo-activation, mRNA
transcription is restored. The pattern of light-induced in
vitro transcription (Fig. 3) is very similar to the pattern of
light-induced expression observed in the expression study in rat skin.
As seen in the rat skin study, caged DNA has near background levels of
transcription; mRNA produced by the transcription of a caged pGFP
linear template is only 3.7% of positive control. Further paralleling
the in vivo expression results, the exposure of caged
templates to 365-nm light increases the mRNA production 5-fold to
19% of control. As seen in vivo, complete restoration of
bioactivity was not achieved despite matching the concentration of
controls and caged products by absorbance at 260 nm. However, matching
plasmid concentration using optical absorbance does not take into
account the conformational state of the plasmids, which may be
important for expression (23).
Indeed, a DNA gel comparison with native plasmids or control plasmids
(Fig. 2) shows that a substantial proportion of the caged plasmid is
nicked, which is not seen in native plasmid. Furthermore,
electrophoretic comparison of caged plasmids and caged plasmids exposed
to light also indicates that there is a reversible alteration in caged
plasmid structure produced by exposure to light. The DMNPE-caged
plasmids exhibit lower mobility, resulting in characteristic band
shifts seen in agarose gel electrophoresis (Fig. 2). The greatest
light-induced change is seen in the pair of relaxed conformation bands
with apparent linear molecular size of 10 kilobases. In the caged
state, the distribution of plasmid between the two relaxed bands is
approximately equal. After exposure to light, 70% of the relaxed form
appears in the more mobile band. These shifts are consistent with the
addition of the nonpolar DMNPE groups that retard plasmid mobility by
neutralizing negative charges on the phosphate linkages of the DNA backbone.
The characteristic absorbance of the DMNPE cage groups provides a
convenient means to compare caged plasmids with other caged moieties.
For example, light-induced changes in the absorbance of DMNPE-caged
plasmid are similar to those observed with commercially available caged
ATP (Fig. 1). The absorbance spectrums of DMNPE-caged ATP (Molecular
Probes) and DMNPE-caged pGFP plasmid show similar peaks in absorbance
at 355 nm (lower curves). Absorption at this wavelength is consistent with the presence of DMNPE caging groups, since native ATP and DNA do not absorb in this region. Approximately 5 min after a 20-min exposure to 365-nm light, similar increases in
absorbance at 390 nm are observed for both compounds as a result of
photolysis of the caging group (upper curves).
These characterize the end result photoproducts and do not compare
measurement of rapid photolysis events, such as those previously
reported for caged ATP (12, 16).
Although no structural studies have been completed, a probable location
of the reactive site on DNA is at the negatively charged phosphate
backbone, with the most likely configuration illustrated in Fig.
6. The choice of this site is consistent
with the attachment of this caging group to other moieties, which
occurs at weak oxy acids, such as carboxylic acids and phosphates
(16).
Based on the extinction coefficient of DMNPE-ATP, the number of caging
groups per plasmid was determined from increases in 355-nm absorption
after caging (Fig. 1). Although the pGreenLantern plasmid has ~10,000
phosphate sites available for caging, these calculations suggest that
only ~270 cage groups are present. These caging reaction conditions
apparently produce a low rate of reaction, since this is less than 3%
of available phosphate sites.
Expression levels of the flashed caged plasmids in vivo
(Fig. 4) and in vitro mRNA transcription levels (Fig. 3)
both indicate that the plasmids remain viable after the addition and
removal of the caging group. Furthermore, this does not appear to be a plasmid-specific phenomenon, since the caging technique is effective with several reporters (pGreenLantern, Fig. 2; pCEP4 Luciferase, Fig.
4;
-galactosidase, data not shown (24, 25)). However, under these
experimental conditions, expression of these caged plasmids exposed to
light never achieved that same level as native plasmid expression.
In the in vivo experiment, one possible explanation for
incomplete restoration is that the optical properties of the skin attenuate 355-nm light, and increased light energy at the skin surface
is needed to completely restore activity. Reduced light delivery to the
gold particles due to light absorption by the skin seems a likely
contributor, since the penetration depth of 355-nm light,
i.e. the depth at which 63% of the light has been attenuated, in human skin is 42 µm (26). Examination of tissue sections of the rat skin samples after transfection by particle bombardment showed that most gold particles reside in the basal epidermis, at a bead depth of 40 ± 28 µm (n = 600 beads). However, light absorbance in the tissue is not the only
factor preventing full re-expression, since it does not explain the
similar expression percentage observed in the in vitro
transcription assay or the HeLa cell expression studies. In this
regard, it is important to note that no selection method was employed
to separate caged intact plasmids from noncaged or damaged plasmids.
After the caging reaction, plasmid structures probably range from
plasmids with no bound cage groups to plasmids with a large number of
cage groups as well as plasmids damaged during the cage reaction. This
may offer an additional explanation of only partial restoration by light exposure. Further optimization by selecting only intact plasmid
with favorable expression conformations should improve the efficiency
of light-induced gene expression from caged plasmids.
Previous reports suggest that the bioactivity of the released
nitrosoketone from the photolyzed caged compound inside the target cell
may be harmful (12, 16, 27). Most biological preparations that use
caged compounds employ relatively high (millimolar) concentrations of
the caged compounds to elicit the desired light-induced effect. At
these concentrations, it has been reported that the reactive
nitrobenzyl groups can form covalent adducts with reactive sulfhydryls,
such as cysteine residues on proteins (12, 16, 27). However, an
important difference between most caging applications and this one is
that the concentration of released photoproduct from caged plasmid is
much lower than the 10
3 M used in most other
caging applications. In the in vitro transcription assay,
the concentration of released photoproduct is calculated to be
~1 × 10
10 M. Based on our previous
HeLa transfection studies (28), the total copies of pGFP are less than
105/cell, which would produce less than 3 × 10
17 mol of cage after photolysis, yielding an upper
limit estimate of photoproduct concentration of 10
6
M. In the rat skin studies, this is more difficult to
determine, but it is expected to be much lower than 10
3
M. While we cannot completely rule out the possibility of
released photoproduct inhibiting re-expression, these inhibitory
effects would be expected to be significantly lower than those seen in other biological studies using caged compounds.
Light at 355 nm falls into the UVA classification and is thought to be
far less damaging to cells than UVB light (28, 29). The maximum light
dosage used to uncage plasmids in these experiments is less than half
of the UVA exposure that might be received in a single visit to a
tanning parlor (28). However, little is known about the inhibitory
effects of 355-nm light on plasmid expression. At this wavelength,
light effects would not be expected, since increased expression is
produced by increased light exposure in the in vivo studies.
However, our GFP cytometry data from cultured HeLa cells after exposure
to 365-nm light (Fig. 4) appear to contradict the in vivo
findings and indicate some inhibitory effects on expression. Further
investigation is necessary to determine how plasmid expression in
cultured cells is affected by 365-nm light.
Interestingly, biochemical inactivation of DNA has a biological
precedent. It perhaps has closest functional homology with DNA
methylation, which occurs under cellular control to regulate transcription (30, 31). Although the mechanism of regulated expression
by methylation is not well understood, DNA methylation and gene
expression have a strong inverse correlation. The addition of a methyl
group is apparently sufficient to block transcription. Similarly, our
data suggest that the attachment of the somewhat larger DMNPE caging
compound also inactivates DNA by blocking transcription.
In summary, this report is the first description of the application of
photosensitive caging compounds and light to target the spatial and
temporal expression of genetic materials. If this strategy proves
useful, additional applications based on this caging technology could
be developed to possibly prolong plasmid expression by protecting
plasmids from methylation and degradation after delivery to cells or
perhaps to protect antisense oligonucleotides from enzymatic degradation.
 |
ACKNOWLEDGEMENTS |
We gratefully acknowledge the contributions
of Elizabeth Dworska (tissue culture), John Kozub of the Vanderbilt
University Free Electron Laser Facility (laser exposures),
Jeff Whitsitt (skin transfection studies), Kyle Gee of Molecular Probes
(caging reaction discussions), and Wen-Chi Tseng (flow cytometry). We thank Molecular Probes for generously supplying the caging
compounds and the caged ATP used in these experiments. Plasmids were
prepared in the Molecular Biology Core Facilities of the Skin Diseases Research Center (Principal Investigator George Stricklin) under the
direction of Mari Davidson; rat studies were performed at the Animal
Core Facility of this Center under the direction of Jeff Davidson; and
tissue histology was performed in the Histology Core under the
direction of Lillian Nanney.
 |
FOOTNOTES |
*
This work was supported in part by the Vanderbilt University
Research Council and National Institutes of Health Grants EY10086 and
AR 41943.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
Present address: LSU Medical Center, Shreveport, LA 71130.
To whom correspondence should be addressed: Box 1510B,
Vanderbilt University, Nashville, TN 37235. Tel.: 615-322-6622; Fax: 615-343-7919; E-mail: haselton@vuse.vanderbilt.edu.
 |
ABBREVIATIONS |
The abbreviations used are:
DMNPE, 1-(4,5-dimethoxy-2-nitrophenyl)diazoethane;
MOPS, 4-morpholinepropanesulfonic acid;
GFP, green fluorescent protein.
 |
REFERENCES |
| 1.
|
Yarranton, G. T.
(1992)
Curr. Opin. Biotechnol.
3,
506-511[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Hart, I. R.
(1996)
Semin. Oncol.
23,
154-158[Medline]
[Order article via Infotrieve]
|
| 3.
|
Stein, G. S.,
Stein, J. L.,
Lian, J. B.,
van Wijnen, A. J.,
and Montecino, M.
(1996)
J. Cell. Biochem.
62,
198-209[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Searle, P. F.,
Stuart, G. W.,
and Palmiter, R. D.
(1985)
Mol. Cell. Biol.
5,
1480-1489[Abstract/Free Full Text]
|
| 5.
|
Mayo, K. E.,
Warren, R.,
and Palmiter, R. D.
(1982)
Cell
29,
99-108[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Furth, P. A.,
St. Onge, L.,
Boger, H.,
Gruss, P.,
Gossen, M.,
Kistner, A.,
Bujard, H.,
and Hennighausen, L.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
9302-9306[Abstract/Free Full Text]
|
| 7.
|
Gossen, M.,
Freundlieb, S.,
Bender, G.,
Muller, G.,
Hillen, W.,
and Bujard, H.
(1995)
Science
268,
1766-1769[Abstract/Free Full Text]
|
| 8.
|
Hynes, N. E.,
Kennedy, N.,
Rahmsdorf, U.,
and Groner, B.
(1981)
Proc. Natl. Acad. Sci. U. S. A.
78,
2038-2042[Abstract/Free Full Text]
|
| 9.
|
Andres, A. C.,
Schonenberger, C. A.,
Groner, B.,
Hennighausen, L.,
LeMeur, M.,
and Gerlinger, P.
(1987)
Proc. Natl. Acad. Sci. U. S. A.
84,
1299-1303[Abstract/Free Full Text]
|
| 10.
|
No, D.,
Yao, T. P.,
and Evans, R. M.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
3346-3351[Abstract/Free Full Text]
|
| 11.
|
Werstuck, G.,
and Green, M. R.
(1998)
Science
282,
296-298[Abstract/Free Full Text]
|
| 12.
|
Kaplan, J. H.,
Forbush, B. D.,
and Hoffman, J. F.
(1978)
Biochemistry
17,
1929-1935[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
McCray, J. A.,
Herbette, L.,
Kihara, T.,
and Trentham, D. R.
(1980)
Proc. Natl. Acad. Sci. U. S. A.
77,
7237-7241[Abstract/Free Full Text]
|
| 14.
|
McCray, J. A.,
and Trentham, D. R.
(1989)
Annu. Rev. Biophys. Biophys. Chem.
18,
239-270[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Adams, S. R.,
and Tsien, R. Y.
(1993)
Annu. Rev. Physiol.
55,
755-784[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Walker, C. J.,
Reid, G. P.,
McCray, J. A.,
and Trentham, D. R.
(1988)
J. Am. Chem. Soc.
110,
7170-7177[CrossRef]
|
| 17.
|
McGall, G.,
Labadie, J.,
Brock, P.,
Wallraff, G.,
Nguyen, T.,
and Hinsberg, W.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
13555-13560[Abstract/Free Full Text]
|
| 18.
|
Chaulk, S. G.,
and MacMillan, A. M.
(1998)
Nucleic Acids Res.
26,
3173-3178[Abstract/Free Full Text]
|
| 19.
|
Molecular Probes.
(1997)
Photoactivatable ("Caged") Probes Product Information Sheet
, Molecular Probes, Inc., Eugene, OR
|
| 20.
|
Tseng, W.-C.,
Haselton, F. R.,
and Giorgio, T. D.
(1997)
J. Biol. Chem.
272,
25641-25647[Abstract/Free Full Text]
|
| 21.
|
Benn, S. I.,
Whitsitt, J. S.,
Broadley, K. N.,
Nanney, L. B.,
Perkins, D.,
He, L.,
Patel, M.,
Morgan, J. R.,
Swain, W. F.,
and Davidson, J. M.
(1996)
J. Clin. Invest.
98,
2894-2902[Medline]
[Order article via Infotrieve]
|
| 22.
|
Johnson, P. H.,
and Grossman, L. I.
(1977)
Biochemistry
16,
4217-4225[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Weintraub, H.,
Cheng, P. F.,
and Conrad, K.
(1986)
Cell
46,
115-122[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Haselton, F. R.,
Tseng, W.-C.,
and Chang, M. S.
(1997)
Invest. Opthalmol. Vis. Sci.
4,
S441 (abstr.)
|
| 25.
|
Chang, M. S.,
and Haselton, F. R.
(1997)
Invest. Opthalmol. Vis. Sci.
4,
S441 (abstr.)
|
| 26.
|
Bruls, W. A.,
Slaper, H.,
van der Leun, J. C.,
and Berrens, L.
(1984)
Photochem. Photobiol.
40,
485-494[Medline]
[Order article via Infotrieve]
|
| 27.
|
Dantzig, J. A.,
Higuchi, H.,
and Goldman, Y. E.
(1998)
Methods Enzymol.
291,
307-348[Medline]
[Order article via Infotrieve]
|
| 28.
|
Robert, C.,
Muel, B.,
Benoit, A.,
Dubertret, L.,
Sarasin, A.,
and Stary, A.
(1996)
J. Invest. Dermatol.
106,
721-728[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Schindl, A.,
Klosner, G.,
Honigsmann, H.,
Jori, G.,
Calzavara-Pinton, P. C.,
and Trautinger, F.
(1998)
J. Photochem. Photobiol. B
44,
97-106[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Eden, S.,
and Cedar, H.
(1994)
Curr. Opin. Genet. Dev.
4,
255-259[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Ramsahoye, B. H.,
Davies, C. S.,
and Mills, K. I.
(1996)
Blood Rev.
10,
249-261[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
X. Tang, J. Swaminathan, A. M. Gewirtz, and I. J. Dmochowski
Regulating gene expression in human leukemia cells using light-activated oligodeoxynucleotides
Nucleic Acids Res.,
February 2, 2008;
36(2):
559 - 569.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.